Oncology Partnerships Strong focus on hematologic malignancies and ongoing trials with ziftomenib and KOMET-017, plus a collaborative alliance with Kura Oncology, signaling opportunities for joint market access, payer strategy, and clinical development partnerships in North America.

NA Growth Leadership A North American footprint across Princeton, Toronto and La Jolla with a recent COO appointment demonstrates growth ambition and leadership alignment, creating openings for regional market access programs, KOL engagement, and channel partnerships to accelerate commercialization.

Digital Selling Enablement Investments in AI and field sales tools, including an LLM engine and data-rich tech stack with IQVIA and CRM platforms, offer sales enablement and real world data opportunities for campaign optimization, post launch studies, and lifecycle management.

Patient Access & Advocacy Active partnerships with patient-focused groups and tools for disease staging indicate a commitment to patient outcomes, enabling collaboration on real-world evidence programs, patient education initiatives, and access solutions for oncology therapies.

Global Ops & Manufacturing As a global specialty pharma with biotech roots, Kyowa Kirin presents opportunities for manufacturing and supply chain collaboration, regional distribution partnerships and services that support scaled launches across North America and beyond.